Literature DB >> 9615906

Lack of influence of apolipoprotein E4 on lipoprotein levels in the island population of Sardinia.

L Deiana1, G M Pes, C Carru, A Errigo, S Pettinato, C Carcassi, G Baggio, L Contu.   

Abstract

BACKGROUND: In this study, the apolipoprotein E (apoE) genotypes as well as plasma lipid and lipoprotein levels have been determined for the first time in 633 healthy and unrelated inhabitants on the island of Sardinia (291 men and 342 women, age range 6-89 years), randomly selected in the four districts of Sardinia among healthy people having parents and grandparents born in the same geographic area. This island lies in the centre of the western Mediterranean sea with a well-recognized peculiar and preserved genetic background. The epsilon 3 allele frequency (0.897) is higher than that previously reported in southern and mainland Italy and is one of the highest in Europe and among Caucasians; epsilon 2 allele frequency (0.040) is the lowest in Europe; epsilon 4 (0.063) is unusually low and, most interestingly, does not change in the different age groups, i.e. does not decrease in old subjects.
RESULTS: Lipid and lipoprotein analysis confirm that total cholesterol and low-density lipoprotein (LDL)-cholesterol levels are lower than those described in mainland Italy; moreover, in this large Sardinian series, accurately selected, epsilon 4 allele did not influence total cholesterol (P = 0.270), LDL-cholesterol (P = 0.667) and high-density lipoprotein (HDL)-cholesterol (P = 0.549) as in other populations. In contrast, subjects carrying the epsilon 2 allele were found to have significantly lower total cholesterol (P = 0.001) and LDL-cholesterol (P = 0.001) levels than epsilon 3 carriers.
CONCLUSION: The low epsilon 4 frequency and the lack of influence of this allele on lipid metabolism is a unique characteristic and, to date, has been described only in Sardinia among Caucasians; it might contribute to the low prevalence of coronary artery disease in this island.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9615906     DOI: 10.1046/j.1365-2362.1998.00271.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

1.  Apolipoprotein E4 polymorphism as risk factor for coronary heart disease among Indian subjects.

Authors:  Tester F Ashavaid; Seema P Todur; Kappiareth G Nair
Journal:  Indian J Clin Biochem       Date:  2002-01

2.  ApoE polymorphism in a small Mediterranean island: relationships with plasma lipids, lipoproteins and LDL particle size.

Authors:  C M Barbagallo; F Polizzi; M Severino; M Rizzo; N Vivona; F Onorato; R Caldarella; A B Cefalù; D Noto; A Notarbartolo; M R Averna
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  The effect of apolipoprotein E polymorphism on lipid levels in Korean adults.

Authors:  Min-Ho Shin; Hee-Nam Kim; Lian-Hua Cui; Sun-Seog Kweon; Kyeong-Soo Park; Heon Heo; Hae-Sung Nam; Seul-Ki Jeong; Eun-Kyung Chung; Jin-Su Choi
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

4.  Impact of APOE gene polymorphisms on the lipid profile in an Algerian population.

Authors:  Houssam Boulenouar; Sounnia Mediene Benchekor; Djabaria Naïma Meroufel; Sarah Aicha Lardjam Hetraf; Hadjira Ouhaibi Djellouli; Xavier Hermant; Benjamin Grenier-Boley; Imane Hamani Medjaoui; Nadhira Saidi Mehtar; Philippe Amouyel; Leila Houti; Aline Meirhaeghe; Louisa Goumidi
Journal:  Lipids Health Dis       Date:  2013-10-25       Impact factor: 3.876

5.  The effects of apolipoprotein E genotype, α-synuclein deficiency, and sex on brain synaptic and Alzheimer's disease-related pathology.

Authors:  Roni Bar; Anat Boehm-Cagan; Ishai Luz; Yarden Kleper-Wall; Daniel M Michaelson
Journal:  Alzheimers Dement (Amst)       Date:  2017-09-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.